Highlights
 A new series of gold(I) NHC complexes have been synthesized and characterized  A pentafluorophenolic ester as an activable moiety for further functionalization  The compounds possess promising antiproliferative properties in cancer cells
Introduction
Currently, metal-based drugs are used in clinic in a regular basis as anticancer chemotherapic agents. In fact, the platinum-based drugs cisplatin, carboplatin and oxaliplatin, are present in more than 75% of anticancer chemotherapic cocktails. 1, 2 However, despite their great clinical success, these drugs present major drawbacks such as the limited spectrum of action, development of resistance, and severe side effects that narrowed their range of applicability. To overcome such drawbacks, one of the most explored strategies consisted in the replacement of platinum by other transition metals. This approach already gave promising results in the case of ruthenium, iron, gold and titanium coordination and organometallic compounds among others. [3] [4] [5] [6] [7] [8] In particular, gold(I) complexes have appeared in the last decades as very potent cytotoxic agents; 9-12 the most famous example being ((2,3,4,6-tetra-O-acetyl-1-(thio-kS)--D-glucopyranosato)(triethylphosphine)gold(I)) (auranofin) already in the clinic as anti-arthritis agent ( Figure 1 ). 13 As a matter of fact, gold is the most noble of the elements and it certainly holds a central place in the world of finance, art and jewelry. Nowadays, the medicinal uses of gold compounds are the subject of intense studies. Conspicuous experimental evidence has been gathered so far to suggest that the pronounced antiproliferative effects caused by gold compounds most likely arise from innovative mechanisms of action in comparison to established anticancer drugs.
Following the successful application of gold phosphine complexes as antitumor agents, Berners-Price and coworkers have pioneered the application of a variety of cationic mononuclear gold(I) N-heterocyclic (NHC) biscarbene complexes as potential chemotherapeutic agents (an example is reported in Fig. 1 ). 14 Since then a number of Au(I)-NHC carbene compounds have been synthesized and characterized for their biological properties, and the studies on this family of organometallic compounds have been reviewed on a regular basis in the past few years. [15] [16] [17] [18] Indeed, Au(I)-NHC compounds present a variety of different derivatization possibilities associated to the possible presence of an ancillary ligand coordinated to gold, in addition to the Au-NHC bond (e.g. phosphines, thiols, as well as a second NHC ligand, as depicted in Figure 1 ). 19, 20 Contrary to platinum derivatives, it has been shown that several Au(I)-NHC complexes induce apoptosis via targeting mitochondria, but also through the interaction with different proteins/enzymes (e.g. thioredoxin reductase). 21, 22 Of note, physicochemical and biological properties of metal complexes have been improved through various strategies, among which the concept of multinuclearity. Indeed, a number of platinum, 23 ruthenium and gold-based homo-or heteropolynuclear complexes, either bi-or polymetallic, have been developed by us and others and biologically tested. [24] [25] [26] [27] [28] [29] In this context, we describe here the synthesis and characterization of new Au(I)-NHC compounds among which three of them bear a pentafluorophenolic ester group as a possible "activable" moiety for further functionalization. In order to prove this concept, one of the In order to obtain a cationic bis-NHC metal derivative, we used a classical method 33 starting from salts containing a non-halide anion, which is then reacted with silver oxide yielding the silver bis-NHC complex, acting as an halide abstractor and ligand transfer agent. L.HBr was thus reacted quantitatively with an excess of sodium tetrafluoroborate to lead to the tetrafluoroborate analogue L.HBF 4 . The latter was reacted with silver(I) oxide and half an equivalent of [AuCl(tht)] to afford the cationic bis-NHC complex 3 in 60% yield (Scheme 1), whose formation was confirmed by reacted with one equivalent of the amine in acetonitrile under microwave irradiation and the best reaction conditions were found to be heating at 80°C for 30 minutes (Scheme 2); higher temperatures lead to partial decomposition of the gold complex even when using a shorter reaction time. It is also worth noting that no additional base was used to prevent any degradation of the carbene. The coupling product (4) was simply purified by precipitation and obtained in very good yield (87 %).
Results and discussion

Synthesis and structural characterization
Applying these optimized reaction conditions, we then reacted complex 1 with the 2-aminoethyldiphenylphophine gold(I) chloride complex and obtained the desired bimetallic complex (5) in very good yield (86 %) (Scheme 2). In an attempt to enlarge the scope of polymetallic complexes, both cationic complexes 2 and 3 were reacted with one or two equivalents of 2-aminoethyldiphenylphosphine gold(I) chloride respectively. However, even though the coupling through the activated ester occurred, a redistribution of the ligands was observed, yielding to a mixture of products in both cases.
Antiproliferative activities
The new compounds were screened for their antiproliferative properties in human ovarian cancer cell lines sensitive (A2780) using the classical MTT assay (see Experimental for details). In addition, in order to evaluate the compounds' selectivity for cancerous compared to healthy cells, the complexes were also tested in human embryonic kidney HEK-293T cells.
A dose-dependent inhibition of cell growth was observed in all cell lines with IC 50 values ranging from ca. 2 to 122 μM after 72 h incubation as depicted in Table 1 X-ray diffraction data for 3 were collected on a Nonius Kappa CCD at 115 K. Microwave reactions were carried on in an Anton Paar Monowave 300 apparatus.
Synthesis
1-methyl-3-{4-[(perfluorophenoxy)carbonyl]benzyl}imidazolium tetrafluoroborate (L.HBF 4 )
A round-bottom flask was filled with 279 mg of 2 (0.60 mmol) and 200 mg of NaBF 4
(1.81 mmol) in 20 mL of acetone. The reaction was maintained at room temperature overnight. After removing of acetone under vacuum, the obtained white solid was partially dissolved in 30 mL of dichloromethane, and filtrated through paper to give a colorless solution. Dichloromethane was then evaporated under vacuum to lead to the pure product (98 % yield (
1-methyl-3-{4-[(perfluorophenoxy)carbonyl]benzyl}imidazole-2-ylidene)(triphenylphos phine)gold(I) tetrafluoroborate (2)
A Schlenk tube was filled with 40 mg of 1 (0.065 mmol) and 18.7 mg of PPh 3 (0.072 mmol) which were dissolved into 4 mL of distilled dichloromethane. AgBF 4 in solution in methanol was added dropwise at room temperature. The reaction was maintained for one hour during which a white precipitate appeared and became grey after some minutes. After a filtration over fritte with celite, the volatiles were removed under vacuum to afford a colorless oil which gave rise to a white precipitate after being washed with 
General procedure for the microwave-based coupling reactions:
A microwave 10 mL-tube was charged with 1 and H 2 N-CH 2 -R (1 eq.) dissolved in distillated acetonitrile. The mixture was reacted in microwave oven (quick heating from r. t. to 80°C, 850
W, stirring at 600 rpm) at 80°C (temperature checked by IR probe) for 30 min (50 W, stirring at 600 rpm). After evaporation of the acetonitrile, the product was redissolved in dichloromethane and filtrated through celite. After partial removal of dichloromethane and addition of a large amount of pentane, the obtained precipitate was filtrated and dry under vacuum to give the pure product.
chlorido{1-methyl-3-[4-(2-phenylethylcarbamoyl)benzyl]imidazol-2-ylidene}gold(I) (4)
1 (50 mg, 0.081 mmol) was dissolved in the tube into acetonitrile (4 mL) and 2-phenylethylamine (0.081 mmol, 10 µL) was added dropwise.
Product as a light yellow powder (38.9 mg, 87 % yield). 
X-ray crystallography
Crystals of 2 were obtained by slow evaporation of a dichloromethane/pentane (1/4) solution.
Intensity data were collected on a Bruker APEX II at 115 K. The structure was solved by direct methods (SIR92) 36 and refined with full-matrix least-squares methods based on F 2 (SHELXL-97) 37 with the aid of the WINGX program. 38 All non-hydrogen atoms were refined with anisotropic thermal parameters. Hydrogen atoms were included in their calculated positions and refined with a riding model. Crystallographic data are reported in Table 2 .
CCDC reference is 981279. 
Antiproliferative assay
The human ovarian cancer cell line A2780 was obtained from the European Centre of Cell
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Reviewer 1:
The paper deals with the synthesis of five new N-heterocycliccarbenegold(I) derivatives, their characterization and antiproliferative properties against A2780 human ovarian cancer cell lines. The chemistry is nice, being short and the antiproliferative properties are interesting, not exceptional, although as a whole the paper rises the novelty and importance to be accepted as JOM full paper.
Nevertheless the paper must be rewrite in many aspects before publication.
1.-Abstract and conclusion contains sentences that should be in the introduction. See for example the first sentence in Abstract and the first three of the conclusion; they are perfect for an introduction and nothing more. In addition the conclusion should be shortened.
Answer: we have moved part of the sentences from the Conclusion section to the Introduction as suggested by this reviewer. We prefer to maintain the Abstract unaltered also to provide the right context to our synthesis, which is the possible medicinal applications of Au NHC complexes. 
